Prostate Cancer International is
for 2011 by Great NonProfits
In February we reported on a presentation by Sheets et al. at the Genitourinary Cancer Symposium. The presentation addressed the comparative effectiveness and safety of 3D conformal, intensity-modulated, and proton beam forms of radiation therapy (3D-CRT, IMRT, and PBRT, respectively).
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: 3D-CRT, comparative, effectiveness, IMRT, localized, outcome, PBRT, radiation | Leave a Comment »
Over the past 20 years there has been an explosion in the different ways that we use varied types of external beam radiation therapy for the treatment of localized and locally advanced forms of prostate cancer. Where is the newly diagnosed patient able to find a good, basic introduction?
Filed under: Management, Treatment | Tagged: 3D-CRT, CyberKnife, EBRT, external beam radiation therapy, IGRT, IMRT, introduction, PBRT, SBRT, TomoTherapy | 2 Comments »
For men undergoing the combination of external beam radiation therapy (EBRT) and androgen deprivation therapy (ADT), for treatment of prostate cancer there is a significant risk for gastrointestinal (GI) toxicity over time.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: 3D-CRT, ADT, androgen deprivation, EBRT, gastrointestinal, IMRT, toxicity | Leave a Comment »
According to a media release from the University of Pennsylvania Health System, (and another from the American Society of Radiation Oncology [ASTRO]), intensity-modulated radiation therapy (IMRT) is associated with fewer complications than traditional, three-dimensional conformal radiation therapy (3D-CRT) in the treatment of non-metastatic prostate cancer.
Filed under: Living with Prostate Cancer, Management | Tagged: 3D-CRT, conformal, IMRT, intensity-modulated, outcome, radiation, side effects | Leave a Comment »
Several years ago, Bolla et al. planned and carried out the major European trial showing that external beam radiation therapy with 3 years of androgen deprivation therapy (ADT, using goserelin acetate) extended the prostate cancer-specific and the overall survival of patients with high-risk localized prostate cancer as compared to radiation alone.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: 3D-CRT, ADT, androgen deprivation therapy, chemohormonal, docetaxel, radiation | 2 Comments »
A South Korean research team has just published data from a small, prospective, case-matched study comparing outcomes after cryotherapy + androgen deprivation therapy (CT + ADT) to outcomes after three-dimensional conformal radiation therapy + androgen deprivation (3D-CRT + ADT) in patients with high-risk prostate cancer.
Filed under: Management, Treatment | Tagged: "high risk", 3D-CRT, ADT, androgen deprivation therapy, conformation-beam, cryotherapy, outcome, radiation, three-dimensional | Leave a Comment »
A few days ago we reported on a study which concluded that the addition of high-dose-rate (HDR) brachytherapy to intensity-modulated radiation therapy (IMRT) had limited short-term clinical benefit in the treatment of localized prostate cancer compared to IMRT alone. Newly published Australian data is arguably supportive of this viewpoint.
Filed under: Management, Treatment | Tagged: 3D-CRT, brachytherapy, conformational radiation therapy, HDR, high-dose-rate, outcomes, three-dimensional | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site